This PhD-project focus on the radiographic issues of mammographic screening, and aims to investigate how breast compression is performed in clinical practice of breast cancer screening today.
It is known that some of the chemical substances in oil can be carcinogenic. The purpose of these studies is to study the prevalence of cancer among Norwegian Offshore workers and study possible relationships between exposure from the working environment and the development of cancer.
HPVseq is an cross-institutional research group with three the main goals, To discover HPV biomarkers, delineate HPV evolution and develop HPV detection and characterization methods.
- A research project aimed at improving the efficiency and quality of the national screening program – BreastScreen Norway - by combining automatic image analysis and radiological expertise.
Presence of certain bacteria in the gut are strongly associated with colorectal cancer. This project is a sub-study within the Bowel Cancer Screening in Norway (BCSN) trial that aims to discover gut microbiota biomarkers for colorectal cancer screening.
NORCCAP (Norwegian Colorectal Cancer Prevention) is a randomized study on screening for colorectal cancer (CRC) and adenomatous polyps (potential precursor lesions for colorectal cancer). The project arose from an initiative made by the Norwegian Gastrointestinal Cancer Group (NGICG) and the Norwegian Cancer Society with funding from the Norwegian Cancer Society and the Ministry of Health and Social Affairs.
A PhD project will investigate aspects of over- and underdiagnosis in BreastScreen Norway. The goal of the project is to add to what is known about the potential harms of mammographic screening.
Based on data from the "Oslo Ischemia Cohort" and The Cancer Registry of Norway, this study aim to assess relationships between physical activity, fitness and cancer.
This postdoc project will estimate the risk of developing invasive breast cancer among Norwegian women with prior benign breast disease or premalignant breast lesions, and study risk factors for progression.
Sun exposure is the most important risk factor of cutaneous melanoma, but several studies have suggested that some prescripted drugs also may play a part. This project aims to investigaste if prescripted drugs influence the risk of, and death due to cutaneous melanoma and provide better and more targeted prevention of cutaneous melanoma through the identification of high-risk persons.
Small noncoding RNAs (sncRNA) are involved in numerous cellulary processes in cancer development. We are currently investigating sncRNA as early detection and potential screening biomarkers of cancer.
The tomosynthesis studies in Bergen, the To-Be studies, are aimed at investigating whether screening with digital breast tomosynthesis is a better screening tool than standard digital mammography for BreastScreen Norway.
Cutaneous Malignant Melanoma is largely caused by exposure to ultraviolet radiation (UVR). UVR is also our main source of vitamin D,which have been associated with reduced risk of some cancers. The situation for melanoma is unclear, as both low and high vitamin D levels have been associated with increased risk.